Gal Gadot has heard some of your Cleopatra criticism — and she’s unfazed.
With U.S. markets shut for a holiday on Monday and Joe Biden set to be inaugurated as the next U.S. president on Wednesday, major currencies remained within established ranges, watching carefully the new administration's stance on the currency. Outgoing President Donald Trump has publicly railed against the dollar's strength for years, but Janet Yellen, Biden's pick to take over the U.S. Treasury, is expected to make clear that the United States does not seek a weaker dollar, according to the Wall Street Journal.
Frank Lampard needs a big performance in order to kickstart Chelsea’s faltering season
It’s ‘very difficult to plan’ for international trips, says Dominic Raab
Third Avenue Management, a disciplined, value-oriented asset manager and investment fund, published its third-quarter 2020 Investor Letter – a copy of which can be downloaded here. A return of 10.94% was recorded by the fund for the 3rd Quarter of 2020, ahead of its FTSE EPRA NAREIT Developed benchmark that returned 10.32%. You can view the […]
The Third-party Banking Software Market will grow by USD 3.04 bn during 2020-2024
President-elect Joe Biden will take the stage for his inaugural address at perhaps the most difficult starting point for a president since Franklin Roosevelt began his first term by assuring a nation scarred by the Great Depression that “we have nothing to fear but fear itself.” Former President Barack Obama in his memoir noted that singer Aretha Franklin’s showy hat and a glitch in Chief Justice John Roberts' administration of the oath of office got more attention than his speech in the days following the first Black president’s address, delivered as the nation was mired in recession and a growing malaise over two intractable wars. Now, with the coronavirus raging, unemployment claims soaring and partisan divisions sharpening, Biden faces a fraught moment as he prepares to deliver a speech that aides say he wants to use to “call Americans to unity.”
Lumps and bumps and growths—oh, my! While skin tags on dogs generally aren’t a cause for concern, you’ll need a veterinarian’s help to determine whether what you’ve found is harmless or cancerous.
The Treasury said on Monday that more than 1.4 billion government-backed loans have been taken up by businesses and used to support jobs around the UK since the pandemic broke out. Chancellor Rishi Sunak said the loans have helped to protect jobs and livelihoods up and down the country, and reiterated a commitment to safeguard employment and create opportunity. The retail and construction sectors were the biggest beneficiaries, according to the Treasury’s data, with regions "receiving loans proportionately to the amount of businesses located there".
During the first ten months of 2020, US importation of overseas softwood lumber was 39% higher than during the same period in 2019. By year-end, 2020's import volume will likely be close to 4.7 million m3, the highest level in 15 years.
Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Cody Ware will pilot the Nurtec® ODT (rimegepant) #51 Chevrolet Camaro for Rick Ware Racing during the 2021 NASCAR Cup Series season. The first race of the season with Cody behind the wheel is the DAYTONA 500, at Daytona International Speedway on February 14.
The "World - Remelting Scrap Ingots Of Iron Or Steel - Market Analysis, Forecast, Size, Trends and Insights" report has been added to ResearchAndMarkets.com's offering.
Innovative Virtual Care Network formed to enhance patient care in long-term care facilities with access to Third Eye Health Physicians, who provide virtual urgent and emergent care. ACO physicians and affiliated providers leverage Third Eye Health’s one-touch telehealth technology to deliver care.KENNETT SQUARE, Pa., Jan. 18, 2021 (GLOBE NEWSWIRE) -- With the spotlight on long-term care facilities during the current public health emergency, leaders in post-acute and long-term care, LTC ACO, the first long-term care Medicare Shared Savings Program dedicated to long-term care residents in the United States, and Third Eye Health, have joined forces to improve the quality of care available for the 6,000 LTC ACO beneficiaries across more than 200 long-term facilities and for all future LTC ACO beneficiaries. Third Eye Health, the nation’s largest virtual care network for post-acute, brings acute-level care virtually to the bedside through its proprietary one-touch telehealth technology. Together, LTC ACO and Third Eye Health are forming a Virtual Care Network, a relatively new concept in the long-term care arena. This innovative approach utilizes Third Eye Heath’s customizable, mobile technology, bringing access to Third Eye Health Physicians, specialists and local providers directly to the bedside of LTC ACO’s beneficiaries. Most LTC ACO participating provider groups and long-term care facilities will be able to use Third Eye Health’s telehealth technology for virtual visits. Third Eye Health physicians, a network of board-certified physicians specially trained to provide acute-level care to post-acute and long-term patients, will cover nights and weekends, creating 24/7 physician access, alleviating the call burden for associated provider groups. “LTC ACO’s affiliated company, Genesis Physician Services, has already benefited greatly from Third Eye’s nights and weekend coverage, with a reduction in return to hospital rates and improved patient outcomes,” remarked LTC ACO President, Jason Feuerman. “Genesis physicians benefit greatly from the call coverage relief Third Eye Health provides, directly impacting a noticeable reduction in physician burnout. The care quality from Third Eye Health Physicians offers timely coordination of care and complements the attending physician’s efforts to improve quality and outcomes,” remarked LTC ACO Chief Medical Officer, Dr. Richard Feifer. Through LTC ACO, long-term care facility operators incur no additional expense to access the Third Eye Network and with 24/7 physician access, it can be expected that quality measures and outcomes will improve. When these goals are attained, LTC ACO, its physicians, long-term care facility partners, and now Third Eye Health, will share in the savings. In 2019, LTC ACO experienced a 19.6% cost savings rate with a 94.5% quality score resulting in Medicare fee-for-service savings and earning the ACO $18.8 million in shared savings distribution. “This is a new venture for both organizations, but one that makes sense from every perspective. Patients, nurses, physicians, administrators, and operators – everyone benefits from the Virtual Care Network. We have seen this success time and time again with Genesis, having a 94% national treat in place rate, patients receive proper acute-level care without the disruption of being transferred to the hospital,” says Dan Herbstman, Founder and Chief Strategy Officer of Third Eye Health. ABOUT LTC ACOLTC ACO is the first post-acute care sponsored Accountable Care Organization (ACO) in the United States. LTC ACO is a subsidiary of Genesis HealthCare and began participating in the MSSP in 2016. Visit our website at www.ltcaco.com. About Third Eye HealthThird Eye Health provides world-class medical care in the post-acute and long-term care settings, preventing unnecessary trips to the hospital. Through its comprehensive platform, Third Eye Health has developed the nation's largest post-acute virtual care network. Third Eye Health’s proprietary technology, care coordination services, and physician led night & weekend virtual urgent care provides nurses access to immediate patient care at the bedside. The organization’s esteemed network of board-certified, licensed physicians work with nurses to reduce unnecessary acute transfers and readmissions. Third Eye Health’s comprehensive program improves the quality of care by lowering adverse events and enhancing regulatory compliance. Visit ThirdEyeHealth.net to learn more. Media Contact: Lori MayerLTC ACOC: 610-283-4995 Jen BradleySenior Marketing DirectorThird Eye Healthjbradley@thirdeyehealth.netC: 847-280-1740
There are four more instalments of James Cameron's sci-fi epic in the works
Third Avenue Management, a disciplined, value-oriented asset manager and investment fund, published its third-quarter 2020 Investor Letter – a copy of which can be downloaded here. A return of 10.94% was recorded by the fund for the 3rd Quarter of 2020, ahead of its FTSE EPRA NAREIT Developed benchmark that returned 10.32%. You can view the […]
Government of Canada announces appointments to the Canadian Centre for Occupational Health and SafetyCanada NewsWireGATINEAU, QC, Jan. 18, 2021 /CNW/ - The Government of Canada is committed to appointing highly qualified candidates to best serve the interests of Canadians.
Welcome Group, LLC has acquired the Tally energy property in West Houston, Texas. The property consists of four office and industrial buildings. It is the latest addition to the commercial real estate owner and developer's growing list of holdings.
Dow Jones futures: The stock market rally pulled back last week as Biden stimulus buzz wanes. Tesla Model Y China deliveries have begun.
‘You seem like an adorable, sweet old lady on the outside,’ actor tells White
Arsenal host Newcastle in the Premier League on Monday 18 January
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Orthopaedic Devices Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering. The orthopaedic devices global market is expected to reach $53,607.2 million by 2027 growing at a high single digit CAGR. Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of orthopaedic device. As a result of rapid advances, there is great expansion in the potential therapeutic application for musculoskeletal injuries, deformities and diseases.The market is primarily driven by the increase in incidence and prevalence of musculoskeletal diseases such as osteoarthritis, osteoporosis, spinal degenerative diseases, spondylitis, lower back pain, herniated spinal discs, and injuries due to trauma and sports activities, increase in the aging population, technological advancement, acquisitions and factors such as product recall, complications associated with implanted devices, lack of skilled and trained professionals to carry out minimally invasive surgery, high cost of the implant, surgery and also stringent regulatory policies for the product approval due to classification of the orthopaedic devices as class II and III devices are hindering the growth of the market.Among products, the spine segment accounted the largest share in 2020 due to technological advancements in the implants, surgery type and increase in the aged population coupled with rise in number of trauma and sports injuries. The extremities segment anticipated as the fastest growing segment and expected to grow at a CAGR of high single digit CAGR from 2020 to 2027 due to increase in the road accident coupled with sports injuries and rise in the geriatric population.The extremities by product type are segmented into upper and lower extremities. Among extremities, the upper extremities accounted for the highest revenue in 2020 and the lower extremities segment is the fastest growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027 as the lower extremities consisting of foot, limb, and ankle are more susceptible to injury and fractures in as a result of trauma and sports activities. The upper extremity products are further segmented into shoulder and other upper extremities. Under upper extremities, the shoulder division accounted for the largest revenue share of the global upper extremities devices revenue in 2020 and is expected to grow at a double digit CAGR of from 2020 to 2027 owing to increased incidence of shoulder dislocation and pain associated as a result of rise in incidence of musculoskeletal diseases, occupational, sports and trauma injuries.The spine segment by product type is segmented into fusion and non-fusion devices. Among the spine device market, the fusion device contributed for the largest revenue share of in 2020 and the non-fusion device division is expected to grow at a double digit CAGR from 2020 to 2027. As a result of rising awareness and better efficiency of spinal stabilization and retention of spinal movements by non-fusion devices as compared to the fusion-devices. Further the fusion device market is categorized into cervical devices, thoracolumbar devices and interbody devices. Among the fusion devices, thoracolumbar devices accounted for the largest revenue in 2020 and the interbody devices are expected to grow at a high single digit CAGR from 2020 to 2027 owing to rapid acceptance of spinal interbody arthrodesis and higher efficiency of reconstruction stability. The non-fusion segment is further classified into artificial disc, dynamic stabilization devices, and annulus repair devices. Among non-fusion devices, the dynamic stabilization device accounted for the largest revenue in 2020 and the artificial discs segment is expected to grow at a double digit CAGR from 2020 to 2027 as the artificial discs aid in the replacement of degenerated discs, movement retention and is the most preferred implant to overcome herniated disc and lower back pain.The orthobiologics segment is further divided into synthetic graft, demineralized bone matrix, machined bone allograft, and others. Among orthobiologics, the machined bone allografts contributed for the highest revenue in 2020 and the demineralized bone matrix is expected to grow at a mid single digit CAGR from 2020 to 2027 owing to improved osteoconductive and osteoinductivity properties as compared to other grafts.The global orthopaedic market by surgery type is segmented into open, minimally invasive and robotic-assisted surgery. Among surgery type, the open surgeries accounted for the highest revenue in 2020 and the robotic assisted surgery is anticipated to grow at a high teen CAGR from 2020 to 2027 due to technological advancements in robotics assisted surgery, favourable reimbursement scenarios for robotic-assisted surgeries and precise and accurate placing of implants with minimal damage to the other tissues and bones. Key Topics Covered: 1 Executive Summary 2 Introduction3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 3.3.1.1 High Prevalence and Incidence of Orthopaedic Disorders and An Increase in the Aging Population 3.3.1.2 Increase in Accidents and Sports Injuries 3.3.1.3 Increasing Demand for Minimally Invasive Surgeries 3.3.1.4 Technological Advancements 3.3.1.5 Acquisition and Collaborations as a Part of the Growth Strategy 3.3.2 Restraints and Threats 3.3.2.1 Product Recalls Due to Manufacturing Errors 3.3.2.2 Lack of Skilled Orthopaedic Surgeon 3.3.2.3 Adverse Events and Complications With the Implantations of Orthopaedic Devices 3.3.2.4 High Cost of Orthopaedic Implants and Surgery 3.3.2.5 Stringent Regulatory Policies 3.4 Regulatory Affairs 3.4.1 International Organization for Standardization 3.4.1.1 Iso 9001: 2015 Quality Management System 3.4.1.2 Iso 13485 Medical Devices 3.4.1.3 Iso /Ts 16782: 2016 Clinical Laboratory Testing 3.4.1.4 Iso 10993 Biological Evaluation of Medical Devices 3.4.2 The U.S. 3.4.3 Canada 3.4.4 Europe 3.4.5 Japan 3.4.6 China 3.4.7 India 3.5 Technological Advancements 3.5.1 Introduction 3.5.2 3D Printing and Development of Patient-Specific Implants 3.5.3 Implant Materials and Coatings 3.5.4 Smart Implants 3.5.5 Evolution in the Robotic-Assisted Surgery With Smaller Incision and Post-Operative Care Reduction 3.6 Implant Materials and Coatings 3.6.1 Metals 3.6.2 Ceramics and Bioglass 3.6.3 Polymer 3.7 Porter's Five Force Analysis 3.8 Supply Chain Analysis 3.9 Reimbursement Scenario 3.10 Patent Scenario 3.11 Funding Scenario 3.12 Market Share Analysis by Major Players 3.13 Orthopaedic Devices Number of Procedures by Region 3.14 Orthopaedic Devices Company Comparison Table by Revenue, Product, Material, and Application 4 Orthopaedic Devices Global Market, by Product 4.1 Introduction 4.2 Knee 4.3 Hip 4.4 Extremities 4.4.1 Upper Extremities 4.4.1.1 Shoulder 4.4.1.2 Other Upper Extremities 4.4.2 Lower Extremities 4.5 Spine 4.5.1 Fusion Devices 4.5.1.1 Cervical Devices 4.5.1.2 Thoracolumbar Devices 4.5.1.3 Interbody Devices 4.5.2 Non-Fusion 4.5.2.1 Artificial Discs 4.5.2.2 Dynamic Stabilization Devices 4.5.2.3 Annulus Repair Devices 4.6 Craniomaxillofacial 4.7 Trauma 4.8 Sports Medicine 4.9 Orthobiologics 4.9.1 Synthetics 4.9.2 Demineralized Bone Matrix 4.9.3 Machined Bone Allograft 4.9.4 Other Orthobiologics 5 Orthopaedic Global Market, by Surgery Type 5.1 Introduction 5.2 Open Surgery 5.3 Minimally Invasive Surgery 5.4 Robotic Assisted Surgery 6 Orthopaedic Devices Global Market, by End-Users 6.1 Introduction 6.2 Hospitals 6.3 Ambulatory Surgical Centers 6.4 Orthopaedic Clinics 7 Regional Analysis 7.1 Introduction 8 Competitive Landscape 8.1 Introduction 8.2 Product Launch 8.3 Product Approval 8.4 Acquisition 8.5 Agreements 8.6 Other Developments 9 Major Companies 9.1 Arthrex Inc 9.1.1 Overview 9.1.2 Financials 9.1.3 Product Portfolio 9.1.4 Key Developments 9.1.5 Business Strategy 9.1.6 SWOT Analysis 9.2 B. Braun Melsungen AG 9.3 Colfax Corporation (Djo, LLC) 9.4 Globus Medical, Inc. 9.5 Johnson & Johnson (Depuy Synthes) 9.6 Medtronic Public Limited Company 9.7 Nuvasive Inc. 9.8 Smith & Nephew plc 9.9 Stryker Corporation 9.10 Zimmer Biomet Holdings, Inc For more information about this report visit https://www.researchandmarkets.com/r/iu8ev1 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
